This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
The most common point of infection in tuberculosis is the mucous membrane of the bronchi and of air passages. It is there that it must be attacked. It does not affect the blood, hence its medication could not interfere with the operations of the germ unless such medication were carried far beyond the ability of the patient to sustain. Stomachic medication is open to the same objection.
The chief reliance of the profession has been cod-liver oil and creosote. The former is a comparatively easily assimilated tissue builder, but is not a remedial agent in any sense of the word. It may temporarily upbuild a patient, but it does not cure because it does not eliminate the bacillus. Having for several years condemned the use of creosote in tuberculous cases, I am glad to note its abandonment by the more observing of the profession, but sorry to see them substituting
LISLE JM. THE TREATMENT OF PULMONARY TUBERCULOSIS. JAMA. 1900;XXXV(16):1021–1024. doi:10.1001/jama.1900.24620420035001p
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: